SOX2 and Alzheimer disease: Specifically, increased circulating miR‐92a‐3p levels were previously found to parallel loss of cognition in AD patients, similarly to miR‐140‐5p, which is activated by amyloid‐β and acts as a negative regulator of SOX2 transcription factor and ADAM1017.